Code
3E013816
Duration
01 October 2016 → 30 September 2019
Funding
Research Foundation - Flanders (FWO)
Promotor
Fellow
Research disciplines
-
Engineering and technology
- Particle design and technology
- Biochemical engineering
Keywords
cancer
nanotechnology
dendritic cells
Project description
The aim of this project is to develop a nanoparticle platform that efficiently delivers tumor assoicated antigens and immuno-modulatory stimuli to dendritic cells in the draining lymph nodes. For this purpose we will combine polymer chemistry, self-assembly and bioconjugation with immunology and oncology. The ultimate goal is to obtain a potent but safe anti-cancer vaccination strategy.